You are here: Industry Insights > COPD

News List

GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD expresspharma
September 18, 2020
Trelegy is the first single inhaler triple therapy approved for the maintenance treatment of both asthma and COPD.
Verona progresses PhII trial of COPD inhaler pharmatimes
August 19, 2020
Verona Pharma is progressing a Phase II trial of new inhaler formulation of ensifentrine following a coronavirus pandemic-induced pause.
AZ' COPD therapy wins US approval pharmatimes
July 27, 2020
AstraZeneca has bagged a green light in the US for Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) as maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), the third leading cause of death globally.
Breztri Aerosphere cut rate of COPD exacerbations in PhIII trial pharmatimes
June 30, 2020
AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) significantly cut the rate of moderate or severe exacerbations compared with two dual-combination therapies in patients with ...
Bevespi Aerosphere approved in China for patients with COPD americanpharmaceuticalreview
May 26, 2020
AstraZeneca’s Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in China as a maintenance treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL expresspharma
April 30, 2020
Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials are indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD).
Ensifentrine improves lung function in COPD patients pharmatimes
April 01, 2020
Verona Pharma has reported positive efficacy and safety data from ensifentrine in chronic obstructive pulmonary disease (COPD) patients.
More Studies Link Vaping to Asthma, COPD drugs
January 15, 2020
Lung illnesses and deaths from vaping have been grabbing headlines for months, and now two new studies offer fresh evidence pointing to long-term respiratory concerns.
Ozone, Wood Smoke Raise Odds of COPD in Smokers and Nonsmokers drugs
January 06, 2020
High levels of ozone and wood smoke each increase the risk for lung diseases like chronic obstructive pulmonary disease (COPD) among smokers and nonsmokers alike, two new studies find.
Environmentally friendly pressurised Metered Dose Inhaler to be developed europeanpharmaceuticalreview
December 09, 2019
A pharmaceutical company has announced its intention to create a pressurised Metered Dose Inhaler that will reduce the carbon footprint of the drug delivery system.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page